Education
About Us
Working with TipRanks
Follow Us
Enveric Biosciences (ENVB)
NASDAQ:ENVB
Total Valuation
Enveric Biosciences has a market cap or net worth of $3.09M. The enterprise value is $1.28M.
Market Cap$3.09M
Enterprise Value$1.28M
Share Statistics
Enveric Biosciences has 2.47M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2.47M
Owened by Insiders45.45%
Owened by Instutions3.84%
Financial Efficiency
Enveric Biosciences’s return on equity (ROE) is -6.01 and return on invested capital (ROIC) is -604.17%.
Return on Equity (ROE)-601.14%
Return on Assets (ROA)-310.62%
Return on Invested Capital (ROIC)-604.17%
Return on Capital Employed (ROCE)-604.74%
Revenue Per Employee$129,418.4
Profits Per Employee-$1,971,255.4
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Enveric Biosciences is -0.28. Enveric Biosciences’s PEG ratio is >-0.01.
PE Ratio-0.28
PS Ratio0.00
PB Ratio1.70
Price to Fair Value1.70
Price to FCF-0.35
Price to Operating Cash Flow-0.35
PEG Ratio>-0.01
Income Statement
In the last 12 months, Enveric Biosciences had revenue of $647.09K and earned -$9.86M in profits. Earnings per share was -$2.56.
Revenue$647.09K
Gross Profit$392.22K
Operating Income-$8.84M
Pretax Income-$9.83M
Net Income-$9.86M
EBITDA-10.40M
Earnings Per Share (EPS)-2.56
Cash Flow
In the last 12 months, operating cash flow was -$8.17M and capital expenditures $15.00, giving a free cash flow of -$8.17M billion.
Operating Cash Flow-$8.17M
Free Cash Flow-$8.17M
Free Cash Flow per Share-$3.30
Dividends & Yields
Enveric Biosciences pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-285.56%
Earnings Yield-353.89%
Stock Price Statistics
Beta1.13
52-Week Price Change-90.96%
50-Day Moving Average1.65
200-Day Moving Average5.45
Relative Strength Index (RSI)31.60
Average Volume (3m)149.40K
Important Dates
Enveric Biosciences upcoming earnings date is May 20, 2025, Before Open.
Last Earnings DateMar 31, 2025
Next Earnings DateMay 20, 2025
Ex-Dividend Date―
Financial Position
Enveric Biosciences as a current ratio of 1.84, with Debt / Equity ratio of 0.00
Current Ratio1.84
Quick Ratio1.84
Debt to Market Cap0.00
Net Debt to EBITDA0.24
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Enveric Biosciences has paid $24.05K in taxes.
Income Tax$24.05K
Effective Tax Rate0.09%
Enterprise Valuation
Enveric Biosciences EV to EBITDA ratio is -0.05, with an EV/FCF ratio of -0.06.
EV to Sales0.00
EV to EBITDA-0.05
EV to Free Cash Flow-0.06
EV to Operating Cash Flow-0.06
Balance Sheet
Enveric Biosciences has $3.11M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$3.11M billion.
Cash & Marketable Securities$3.11M
Total Debt$0.00
Net Cash-$3.11M
Net Cash Per Share-$1.26
Tangible Book Value Per Share$3.08
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Enveric Biosciences is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.00
Price Target Upside700.00%
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast
EPS Growth Forecast82.47%